According to Recursion Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 37.5898.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | 5.59 | 21.68% |
2023-12-31 | 4.59 | 52.67% |
2022-12-31 | 3.01 | -43.58% |
2021-12-31 | 5.33 | |
2020-12-31 | N/A |